2,2,2-Trifluoro-1-(4-methoxyphenyl)ethylamine hydrochloride, 95.0%, 5g

1-(2,6-Dichloro-phenyl)-5-methyl-1H-pyrazole-3-carboxylic acid ethyl ester, 95.0%, 1g

Microliter syringe GASTIGHT® series 1700 Point type 2, 10 µl, 1701 RN, 1 piece

Hexylcyclohexane>98.0%(GC)25mL

(R)-3-((tert-Butoxycarbonyl)amino)-4-(3-fluorophenyl)butanoic acid, 95.0%, 1g

N,N-Dimethylpiperidin-4-amine dihydrochloride, 95.0%, 25g

6-Benzyl-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridin-3(2H)-one, 95.0%, 5g

4,4'-Ethylenedianiline>97.0%(GC)(T)5g

Nicotinamide, 99.00%, 1kg

4-Methoxy-3-methylbenzoic acid, 95.0%, 25g

1-ETHYL-2-PHENYLBENZENE, 95%, 5g

3-Amino-3-(4-methoxy-3-methylphenyl)propanoic acid, 97%, 500mg

Benzylpyridin-3-ylmethylamine, 95.0%, 1g